The new cancer therapies that crossed the gateway of the medical trials are able to treat more than 50 percent of the cancer patients because of their positive results. There are still few patients that did not react to the standard treatment and are looking ahead to get treated by the new medicine to increase their quality of life.
All these patients are eligible for enter into clinical trials conducted to conclude safety and efficiency of the therapy. Phase I stage of the clinical trials are the initial points of the new drug testing that ultimately receives the approval of FDA. The participants of the Phase I cancer clinical trials can accesses the new treatments. This helps the researchers to bring the new drug or treatment to treat the cancer patients suffering from the advanced cancer.
No comments:
Post a Comment